We however observed increased protein levels of the apoptotic mediators PUMA and BAX upon idasanutlin treatment of neuroblastoma cells, but no downregulation of MCL1 protein or any effects on BCL2 protein abundance. The gene discussed is BAX; the disease is neuroblastoma.